Efficacy and safety of rituximab in the treatment of eosinophilic granulomatosis with polyangiitis

Efficacy and safety of rituximab in the treatment of eosinophilic granulomatosis with polyangiitis

Introduction Eosinophilic granulomatosis with polyangiitis (EGPA) is a subset of antineutrophil cytoplasmic antibodies (ANCA) associated vasculitis with distinct pathophysiological mechanisms, clinical features and treatment responses. Rituximab is a licensed therapy for granulomatosis with polyangi...

Full description

Saved in:
Bibliographic Details
Main Authors: David Jayne, Rachel B Jones, Vítor Teixeira, Aladdin J Mohammad, Rona Smith
Format: Article
Language:English
Published: BMJ Publishing Group 2019-06-01
Series:RMD Open
Online Access:https://rmdopen.bmj.com/content/5/1/e000905.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items